Aims/hypothesis. Glutamic acid decarboxylase autoantibodies (GADA) are the most frequent beta-cell-specific autoantibodies in type 1 diabetes and in latent autoimmune diabetes in adults (LADA). The autoimmune attack on pancreatic islet cells is associated with a T helper 1 cell (T h 1) response, mainly represented by IgG 1 -subclass in humans. It has been proposed that the presence of IgG 4 may be associated with a T h 2 response. The aim of our study was to compare the GADA IgG-subclass distribution between adult patients with type 1 diabetes and LADA. Methods. Patients with type 1 diabetes (n=45) and patients with LADA (n=60) were included. Radioimmunoprecipitation assay with IgG-subclass specific Sepharose (IgG 1 , IgG 2 , IgG 3 and IgG 4 ) was used to precipitate the antibody/antigen-complex.
Introduction
Autoantibodies directed against glutamic acid decarboxylase (GADA) and beta-cell-specific tyrosine phosphatase (IA-2A) are frequently found in patients with type 1 diabetes mellitus and latent autoimmune diabetes in adults (LADA). Patients with LADA have a slower progression of beta cell destruction than patients with type 1 diabetes, which is reflected by the higher C-peptide levels found at diagnosis in LADA patients [1] . The phenotype of LADA tends to resemble classical type 2 diabetes, with patients older at clinical onset, with higher BMI, no initial requirement of insulin treatment and more pronounced insulin resistance [2] . Somehow the beta cell destruction in LADA seems to be less aggressive than in type 1 diabetes. The genetics of LADA and type 1 diabetes with onset in adulthood are similar according to the HLAsystem [3] , even though patients with LADA have a lower frequency of risk genes than patients diagnosed with type 1 diabetes in childhood [4] . Another difference between LADA and type 1 diabetes is that LADA patients are more often positive for a single autoantibody, while patients with type 1 diabetes mostly have several autoantibodies [5, 6] .
It is possible that the immune system responds differently in the two forms of autoimmune diabetes. Type 1 diabetes is associated with a T helper 1 cell (T h 1) cytokine profile [7, 8, 9] , in which IgG 1 is the dominating GADA-subclass in humans [8, 10] . In mice beta cell destruction is related to a T h 1-associated response [11] , which is associated with the production of IFN-γ, TNF and IL-2, but also with the generation of IgG 2a and IgG 3 [12] . IgG 4 is more likely to appear together with the cytokines IL-4, IL-5 and IL-13, which are related to a T h 2 response [12, 13, 14] . Our hypothesis is that the profile of IgG-subclasses will reflect the relative balance of T cell subsets and degree of immunogenicity in the destructive process.
The aim of our study was to determine the IgGsubclasses of GADA in patients with type 1 diabetes and LADA and compare the IgG-subclass profile as a reflection of T helper cell response against beta-cellspecific antigens in the two types of autoimmune diabetes.
Subjects and methods
Subjects. Subjects included in this study were clinically classified by the treating physician as having either type 1 or type 2 diabetes. Type 2 diabetic patients with antibody positivity for either one of GADA, islet cell antibody or IA-2 were considered to have LADA. All the patients were above 15 years of age at clinical onset and were diagnosed between 1995 and 2001 in former Malmöhus läns landsting, southern Sweden. The plasma samples were collected as close to diagnosis as possible (clinical data, see Table 1 ). A control group (n=119; median age 30 years; range 19-65 years) consisting of healthy blood donors was used to determine the cut-off level for the respective IgG-subclass. All control subjects signed a form giving informed consent. This study was approved by the Ethical committee at Lund University (LU-44-95 and LU-526-00).
Analysis of IgG-subclass antibodies. Plasma from the subjects was incubated with in vitro translated recombinant 65 M r GAD 65 labelled with 35 S-methonine (20-7149-50, Amersham Biosciences Europe, Freiburg, Germany). Total GADA was analysed with a radioimmunoprecipitation assay [15] . The sensitivity and specificity of this method are 81% and 95% respectively [16] were measured in a beta counter. Quadruplicates of inhouse positive and negative standards and duplicates of each sample were used. The results were expressed as indexes to compensate for background radiation and were calculated in the following way:
where Std stands for standard.
The upper limit for negativity for IgG 1 was an index of 0.04, for IgG 2 an index of 0.12, for IgG 3 0.11, and for IgG 4 an index of 0.06, and was calculated as mean + 3 standard deviations. The inter-assay variation coefficients were determined as 19% for IgG 1 , 17% for IgG 2 , 24% for IgG3 and 21% for IgG 4 . The intra-assay variations for each subclass were determined as 10% for IgG 1 , 6% for IgG 2 , 13% for IgG 3 and 12% for IgG 4 .
Analysis of C-peptide. We analysed C-peptide using a commercial radioimmunoassay kit (Euro-Diagnostica, Malmö, Sweden) at the Department of Clinical Chemistry, University Hospital of Lund, Sweden. The intraassay variation was 5% in the measurement interval 0.5-3.5 mmol/l and total variation (sum of intra-and inter-assay variation) was 7% in the same measurement interval. The detection limit was 0.13 nmol/l and (Table 2) . This was mostly due to the higher frequency of IgG 4 in LADA patients, 16 of whom were IgG 4 -positive.
Some patients had very low concentrations of GADA antibodies when analysed with our standard method for total GADA IgG. Consequently, in 4.4% (2/45) of the type 1 diabetic and in 13.3% (8/60) of the LADA patients, IgG-subclasses were not detectable (Table 3) .
The C-peptide levels were higher in patients with LADA (n=56; median 0.57 nmol/l; range 0.14-1.80 nmol/l) than in patients with type 1 diabetes (n=45; median 0.28 nmol/l; range 0.13-2.50 nmol/l; p<0.001). Patients with LADA also had a higher median age (see Subjects). However, in IgG 4 -positive patients there was no correlation either between the levels of IgG 4 and C-peptide (r s =−0.148; p=NS) or between IgG 4 and age (r s =0.374; p=NS). with non-progressing diabetes [10, 13] , corresponding with the milder T cell response that is thought to occur in these subjects. In contrast to our finding that GADA IgG 4 was detectable only in LADA patients, this subclass has previously been found in early type 1 diabetes [8, 10, 13] . This could be explained by the possible influence of different methods on the finding of IgG 4 in low titres. One study showed that 90% of Chinese type 1 diabetic patients exhibited two or more IgG-subclasses directed against IA-2 [19], while we found that it was more common for patients with type 1 diabetes to express GADA IgG 1 only.
In some patients (two in the type 1 diabetes group and eight in the LADA group) IgG-subclasses were not detected at all, even though all the patients with non-detectable GADA IgG-subclasses had low titres of total GADA (index 0.08-0.19; limit for negativity <0.08). This might be explained by the presence of many different subclasses in levels below the detection limit.
In mice, IFN-γ and IL-2 from T h 1 lymphocytes stimulate the production of IgG 2a and IgG 3 , whereas IL-4 and IL-10 from T h 2 lymphocyte stimulates the synthesis of IgG 1 and IgG 2b [7, 11] . In humans there is no well-defined relation between IgG 2 and IgG 3 and specific T cell subsets or cytokines. However, it has been suggested that IgE and IgG 4 are associated with a T h 2 -response [7, 13] . Therefore, results from animal experiments cannot be used directly to interpret findings in human subjects and we cannot conclude whether the immune response in human diabetes is T h 1-or T h 2-related merely on the basis of the IgGsubclass distribution. One way of further clarifying the results would be to measure the cytokine concentrations, as well, but this would have to be performed in the local organ, since analyses in sera or plasma do not elucidate where the cytokines originate. T h 1 and T h 2 coexist in the same individual [20] and may influence cytokine findings in blood. For example, a virus infection that is T h 1-dominated results in the release of T h 1-related cytokines such as TNF and IFNγ. Allergy and asthma on the other hand are T h 2-dominated and patients with coexisting allergies might have elevated levels of IL-4, IL-5 and IL-13 in sera. If cytokines are used as markers for T h 1/T h 2 dominance, they should preferably be measured directly in the tissue where the cytokines are released and not systemically in the circulation.
We found a dominance of IgG 1 in type 1 diabetic and LADA patients, and this is likely to reflect a dominant T h 1 response against GAD 65 in pancreatic tissue. Differences in IgG-subclass distribution against GADA and IA-2A among patients with type 1 diabetes have been reported and IgG 1 is the most frequently occurring subclass in all studies so far [8, 13, 19, 21, 22] . However, little is known about the IgG-subclasses in patients not classified as type 1 diabetic. The lev-
Discussion
We found that the IgG 4 -subclass of GADA was more prevalent in LADA patients than in adult patients with type 1 diabetes, with IgG 4 found in about 30% of the former, but being absent in type 1 diabetic patients. However, when IgG 4 was found, it was always co-expressed with IgG 1 -subclass. IgG 1 was detected in all (i.e. type 1 and LADA) patients in whom subclasses were identified.
To our knowledge, the present study is the largest one to analyse IgG-subclass against GAD 65 in LADA patients and in adult type 1 diabetic patients. The method used, however, has not yet been subjected to international standardisation. Previous studies on IgGsubclasses against GAD and IA-2A have been done in type 1 diabetic patients and in autoantibody-positive first degree relatives of such patients [7, 8, 10, 13, 18] , but only limited data from LADA patients have been reported [10] . Since both GAD 65 and IA-2 are expressed in beta cells and exposed to the same immune cells, the isotype restriction can be expected to be similar. IA-2A restricted to the IgG 4 -subclass have been shown to be associated with protection from type 1 diabetes [18] and GADA IgG 4 have been shown to be associated with slower progression to clinical diabetes [8] , as our study confirms. GADA IgG 4 have also been found in pre-diabetic patients and individuals el of IgG 3 varies considerably between studies, which could be partly explained by the fact that this subclass is not as stable as the other subclasses. In vivo IgG 1 , IgG 2 and IgG 4 circulate for about 21 days while IgG 3 degrades after about 7 days. The handling time of the sample could vary and influence the level of IgG 3 to a greater degree than for the other subclasses.
Even if the T h 1/T h 2 paradigm were an oversimplification [23, 24] , it is highly likely that T h 1 cells and their related cytokines accelerate the destruction of pancreatic beta cells. Some studies have suggested that the T h 2 profile in some way is protective against the aggressive damage inflicted on the insulin-producing cells [25, 26, 27, 28, 29] . Furthermore, in our study the LADA patients, who expressed more IgG 4 , also had better preserved beta cell function at clinical onset. Of course, this could be because patients with LADA have higher expression of T h 2 cytokines in the pancreatic tissue, not high enough to be entirely protected but sufficient to slow down progression to beta cell failure. It is still unclear whether the presence of IgG 4 predicts better preserved beta cell function in LADA patients in the time after clinical onset, and further studies will be needed to clarify this.
We conclude that in some patients with LADA the presence of the IgG 4 -subclass against GAD 65 is an indication of a more balanced immune response in the pancreatic tissue. The dominance of IgG 1 in type 1 diabetes represents a more aggressive T h 1-dominated reaction.
